Kiromic Biopharma Inc.

12/12/2024 | Press release | Distributed by Public on 12/12/2024 07:05

Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post Treatment in Fourth Patient Enrolled in Deltacel 01